-
2661
-
2662
-
2663
-
2664
Clinical Outcomes of Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab for Treating Hepatocellular Carcinoma and Type IV Portal Vein Tumor Thrombus
Published 2025-01-01“…Xiaowei Li,* Kunkun Cao,* Zhigang Fu,* Xiaoxia Chen, Jiaming Zhong, Li Liu, Ning Ding, Xiaoli Zhang, Zengqiang Qu, Lijun Zhu, Jian Zhai Department II of Interventional Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, 200438, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jian Zhai; Lijun Zhu, Department II of Interventional Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai, 200438, People’s Republic of China, Email jianzhai1979@126.com; lijun_zhush@163.comPurpose: To assess the activity and toxicity of hepatic arterial infusion chemotherapy (HAIC)+tislelizumab+lenvatinib (HAIC+tisle+len) in hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) type IV (Vp4 hCC) in a real-world context.Methods: Fifty-five patients, with Vp4 hCC receiving HAIC+tisle+len therapy from April 2021 to December 2022, were analyzed retrospectively. …”
Get full text
Article -
2665
-
2666
Association between occupational exposure to gasoline and anemia: a retrospective cohort study in China
Published 2025-01-01Get full text
Article -
2667
-
2668
Effects of prebiotics on the fermentation of traditional suancai of Northeast China
Published 2024-05-01Get full text
Article -
2669
Polydopamine grafting polyether ether ketone to stabilize growth factor for efficient osteonecrosis repair
Published 2025-01-01Get full text
Article -
2670
Impedance spectroscopy and electrical conductivity of 0.7BiNdxFeO3–0.3BaTiO3 ferroelectric ceramics
Published 2025-04-01Get full text
Article -
2671
-
2672
-
2673
-
2674
-
2675
-
2676
-
2677
-
2678
-
2679
-
2680